SG Americas Securities LLC Boosts Stake in Stepan Company $SCL
SG Americas Securities LLC significantly increased its stake in Stepan Company (NYSE: SCL) by 166.8% in the fourth quarter of the previous year, now owning 46,410 shares valued at approximately $2.20 million. Despite this institutional interest, Stepan missed its Q4 earnings and revenue expectations, reporting ($0.02) EPS against an expected $0.35, and its stock currently has a consensus "Sell" rating from analysts. The company also announced a quarterly dividend of $0.395 per share, yielding 3.2% annually, with a payout ratio of 77.07%.
Stepan Company stock: Steady in volatile materials sector—what you need to watch
Stepan Company (NYSE: SCL) is presented as a stable specialty chemical producer within the volatile materials sector, focusing on surfactants and engineered materials. The article highlights its consistent performance, strategic focus on sustainable chemistry and bio-based products, and reliable cash flows, making it an attractive option for North American investors seeking defensive plays and steady dividends. Despite challenges like raw material volatility and competition, analysts view Stepan as a strong "hold" for long-term income and moderate growth.
Stepan Company stock: Steady in volatile materials sector—what you need to watch
This article analyzes Stepan Company (NYSE: SCL), a specialty chemical producer, as a stable investment in the volatile materials sector, particularly for North American investors. It highlights Stepan's focus on surfactants and engineered materials for essential industries, its commitment to sustainable chemistry, and its consistent dividend history. The author, a Senior Equity Analyst, discusses the company's competitive landscape, key industry drivers, and potential risks, concluding that it's a compelling option for investors seeking stability and moderate growth rather than aggressive returns.
Stepan (NYSE:SCL) Stock Passes Above Two Hundred Day Moving Average - Here's What Happened
Stepan (NYSE:SCL) stock recently traded above its 200-day moving average, reaching $50.58 before settling at $50.095. Despite this, the company faces recent downgrades from several brokerages and missed its quarterly earnings and revenue estimates. Stepan also pays a quarterly dividend, maintaining a dividend yield of approximately 3.2%.
Vanguard (SCL) realigns holdings, reports 0 shares after Jan 12, 2026 realignment
Vanguard Group has filed an Amendment No. 12 to Schedule 13G/A for Stepan Co (SCL), reporting that it holds 0 shares and 0% beneficial ownership of the common stock after an internal realignment effective January 12, 2026. This realignment involves Vanguard and its disaggregated subsidiaries no longer being deemed to beneficially own securities held by those subsidiaries, with all voting and dispositive powers reported as zero. The filing clarifies an administrative ownership adjustment driven by an internal structure change, not affecting Stepan Co's corporate governance or control.
Stepan Company Announces Surfactant Price Increase Effective April 1, 2026
Stepan Company has announced a price increase for its surfactants, effective April 1, 2026. The specific details, including the extent of the increase, are available to logged-in subscribers of Polymerupdate.com. The announcement was made on March 26, 2026, and is categorized under News Desk, Plant News, Important News, and Offer News.
Petrochemical News - Stepan Company Announces Surfactant Price Increase Effective April 1, 2026
Stepan Company has announced a price increase for its surfactant products, effective April 1, 2026. This announcement was made on March 26, 2026, and is available for full viewing to logged-in users of the Polymerupdate platform.
[ARS] STEPAN CO SEC Filing
This article announces an ARS SEC filing by STEPAN CO (SCL) on March 25, 2026, at 06:40 AM UTC. The filing is available as a PDF document through SEC EDGAR. The article also provides a brief overview of Stepan Co.'s stock performance, latest news, and other recent SEC filings.
SCL SEC Filings - Stepan 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Stepan (SCL) SEC filings, including 10-K, 10-Q, and 8-K reports, along with insider trading information. It highlights recent filings such as Dimensional Fund Advisors' 5% stake, various insider stock transactions, and the company's new Key Executive Severance Benefit Plan. The page also features an AI-powered summary of Stepan's Q3 2025 earnings report, including net sales, net income, and dividend declarations.
SCL SEC Filings - Stepan 10-K, 10-Q, 8-K Forms
This page provides a comprehensive resource for Stepan Company (SCL) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, and 8-K material events, alongside AI-powered summaries. Recent filings detail executive changes, insider stock awards (RSUs, performance shares, SARs), and significant transfers of shares through estate distributions. The platform offers real-time updates and tools to analyze these regulatory disclosures.
Numerai GP LLC Boosts Stock Holdings in Stepan Company $SCL
Numerai GP LLC significantly increased its stake in Stepan Company (NYSE:SCL) by 67.7% during the third quarter, now owning 64,721 shares worth approximately $3.09 million. Despite this increased institutional interest, Stepan recently missed quarterly earnings expectations and has received multiple "Sell" ratings from analysts, with its stock currently trading around $46.94 and offering an annualized dividend yield of 3.4%. Hedge funds and other institutional investors collectively hold 82.70% of the company's stock.
Stepan Company Announces Polyol Price Increase for North America effective April 1, 2026
Stepan Company has announced a price increase for its polyol products in North America, effective April 1, 2026. This news was reported by Polymerupdate and requires a login to view the full details of the article. The announcement is part of petrochemical news indicating market adjustments for various chemical products.
Algert Global LLC Increases Stock Holdings in Stepan Company $SCL
Algert Global LLC significantly increased its stake in Stepan Company (NYSE:SCL) by 209.1% in the third quarter, now owning 160,874 shares valued at $7.67 million. Other institutional investors like UBS Group AG and HighTower Advisors LLC also adjusted their holdings in the basic materials company. Despite these investments, Stepan has faced recent downgrades from analysts and reported a quarterly earnings miss.
SCL - Stepan Latest Stock News & Market Updates
This page provides the latest news and market updates for Stepan Company (NYSE: SCL), a specialty and intermediate chemicals manufacturer. It covers financial results, capital investments, corporate governance, and dividend declarations, offering insights for investors. Recent news items include record third-quarter results in 2020, dividend declarations, and the acquisition of Clariant's surfactant business in Mexico.
Invenomic Capital Management LP Invests $8.62 Million in Stepan Company $SCL
Invenomic Capital Management LP recently acquired a new stake of 180,717 shares in Stepan Company, valued at approximately $8.62 million, despite the company's recent earnings miss and a consensus "Sell" rating from analysts. Stepan reported an EPS of ($0.02) against an estimated $0.35 and revenue of $553.9M versus $570.6M. The company also pays a quarterly dividend of $0.395, resulting in an annualized yield of 3.4% with a payout ratio near 77%.
Stepan Company Stock Signals Resilience Amid Chemical Sector Headwinds
Stepan Company (US8585861003) is demonstrating resilience despite chemical sector challenges like margin compression and customer destocking. The specialty chemicals producer, with core segments in surfactants, polymers, and specialty products, is attracting value-oriented European investors. While facing headwinds from input costs and construction weakness, its stable balance sheet, dividend policy, and potential for earnings amplification as destocking eases make it an appealing prospect.
Stepan Company Stock Signals Resilience Amid Chemical Sector Headwinds
Stepan Company operates in a complex chemical sector environment facing margin pressures and shifting demand. The company's stock shows resilience despite challenges like volatile input costs, customer destocking, and regional demand divergence. For European investors, Stepan represents a mid-sized, cyclical play with limited but meaningful European operations, offering stable dividends for value-oriented investors but a balanced risk-reward for growth-oriented ones.
Stepan Company Stock Signals Resilience Amid Chemical Sector Headwinds
Stepan Company, a specialty chemicals manufacturer, is navigating a challenging chemical sector marked by volatile input costs, customer destocking, and regional demand shifts. The company's resilience is tested by margin pressures in its surfactants and polymers segments, though its specialty products division shows more stability. Despite these headwinds, Stepan maintains a disciplined capital allocation strategy, focusing on dividends, strategic investments, and share repurchases, making it relevant for income-focused and value-oriented investors.
American Century Companies Inc. Has $27.98 Million Stock Holdings in Stepan Company $SCL
American Century Companies Inc. significantly increased its stake in Stepan Company, now holding 586,473 shares valued at approximately $27.98 million, representing 2.59% ownership. This move comes as Stepan faces analyst downgrades to "Sell" and missed quarterly EPS and revenue estimates, reporting a net loss of $0.02 per share against a consensus of $0.35. Despite this, the company declared a quarterly dividend of $0.395 per share, resulting in an annualized yield of 3.3%.
STEPAN CO (SCL) CFO receives RSUs, performance shares and SARs
STEPAN CO (SCL) CFO Ruben Dario Velasquez received new equity awards, including 35.601 shares of common stock on February 27, 2026, and grants of 5,993 restricted stock units, 2,996 performance shares, and 8,586 stock appreciation rights on March 2, 2026. These awards are part of his compensation package, with RSUs vesting over three years and performance shares tied to goals ending December 31, 2028. The filing indicates these are compensation grants, not open-market purchases.
Equity awards to Stepan (NYSE: SCL) VP in corrected Form 4
Stepan Company's VP & GM of Surfactants, Sean Thomas Moriarty, received several equity awards including Stock Appreciation Rights, performance shares, and restricted stock units, as detailed in a Form 4/A SEC filing. The filing clarifies that a previous Form 4 incorrectly stated the Stock Appreciation Right amount. These awards include a direct acquisition of 56.765 common shares and generally vest ratably over three years, with performance shares vesting upon Stepan meeting specific goals by December 31, 2028.
A Look At Stepan (SCL) Valuation After Earnings, Goodwill Impairment And Dividend Reaffirmation
Stepan (SCL) recently released its Q4 and full-year 2025 results, showing higher quarterly sales and net income, alongside a goodwill impairment charge and reaffirmed dividends. Despite a stock price decline over the past year, the company's valuation appears undervalued according to analyst targets and multiple intrinsic estimates, presenting a potential buying opportunity. Investors are encouraged to consider the mixed signals of reported profitability, balance sheet adjustments, and cash returns when evaluating the company's future.
Stepan (NYSE: SCL) VP logs RSU share vesting and tax-withholding stock disposals
Stepan Company VP Richard Finn reported restricted stock unit (RSU) vestings and corresponding tax-withholding stock disposals on March 3 and 4, 2026. Finn acquired 1,253 and 429 common shares from RSU settlements, while simultaneously disposing of 434 and 149 shares to cover tax liabilities at prices of $48.985 and $49.615 per share, respectively. He continues to hold additional shares both directly and indirectly through various family members and trusts.
Stepan (NYSE:SCL) Stock Rating Lowered by Zacks Research
Zacks Research has downgraded Stepan (NYSE:SCL) from a "hold" to a "strong sell" rating, and Weiss Ratings also lowered its rating to "sell." This comes after the basic materials company missed its Q4 earnings and revenue estimates. Despite a 5.4% year-over-year revenue increase, the stock fell approximately 2% on the news, with institutional investors owning a significant portion of its shares.
Will Stepan’s (SCL) Persistent Dividend Raises Amid Impairment Recast Its Capital Allocation Narrative?
Stepan Co (SCL) declared its 58th consecutive annual dividend increase to US$0.395 per share, despite reporting a US$6.25 million goodwill impairment and relatively thin net income in Q4 2025. This decision maintains its investment narrative focused on specialty chemicals, capacity expansions, and navigating margin pressures. The article highlights the discrepancy between the dividend increase and the financial impairments, urging investors to consider this in light of varying fair value estimates for the company.
Cresset Asset Management LLC Has $10.65 Million Holdings in Stepan Company $SCL
Cresset Asset Management LLC increased its stake in Stepan Company (NYSE:SCL) by 11.6% in the third quarter, now owning 223,294 shares valued at $10.65 million. Despite this, Stepan missed analyst expectations for its last quarter's earnings and revenue, reporting an EPS of ($0.02) against an expected $0.35. The company recently announced a quarterly dividend of $0.395, with an annualized yield of 3.2% and a payout ratio of 77.07%.
Will Stepan’s (SCL) Persistent Dividend Raises Amid Impairment Recast Its Capital Allocation Narrative?
Stepan Company (SCL) recently declared its 58th consecutive annual dividend raise, setting it at US$0.395 per share, despite reporting a US$6.25 million goodwill impairment and mixed earnings in Q4 2025. This decision prompts a re-examination of the company's capital allocation strategy, especially as it continues to focus on specialty alkoxylation growth and managing operational risks like input costs. The article suggests that while the dividend reinforces investor confidence, the company's ultimate investment narrative will still be heavily influenced by its capacity expansions and efforts to improve profit margins.
Stepan to close capacity
Stepan plans to close its Fieldsboro, New Jersey, site and decommission select assets at its Elwood, Illinois, and Stalybridge, UK, facilities by mid-2026. These actions are part of Project Catalyst, a new operational and efficiency plan aimed at generating $100 million in pre-tax savings over two years. The company anticipates incurring $70-80 million in restructuring charges in 2026 as it optimizes its global manufacturing footprint in response to lower demand for commodity surfactants.
Stepan Company (SCL): A Bull Case Theory
This article summarizes a bullish thesis on Stepan Company (SCL), highlighting its diversified chemical end markets, resilience to commodity price swings, and strong near-term cash flow generation. Despite recent GAAP net income decline due to start-up costs and higher interest, the company shows strengths in Polymers & Specialty and attractive valuation relative to normalized EBITDA. The author suggests it's a core cyclical industrial allocation, with potential upside from successful operational execution and feedstock stabilization.
Stepan Company (SCL): A Bull Case Theory
This article summarizes a bull thesis on Stepan Company (SCL), highlighting its diversified chemical end markets, resilience to commodity fluctuations, and strong near-term cash flow despite mixed Q3 2025 results. Key operational challenges include the Pasadena, TX alkoxylation start-up, but successful commissioning and feedstock stabilization are identified as potential upside catalysts. The company's valuation is considered attractive relative to normalized EBITDA, suggesting an appealing opportunity for cyclical industrial allocation.
STEPAN CO SEC 10-K Report
Stepan Company (SCL) released its 2025 Form 10-K report, detailing financial performance including $2,332.1 million in net sales and a net income of $46.9 million. The report highlights strategic initiatives like footprint optimization and capital management, alongside future outlooks and identified risks spanning operational, market, regulatory, strategic, international, financial, and cybersecurity domains.
Stepan Company (NYSE:SCL) Q4 2025 Earnings Call Transcript
Stepan Company (NYSE:SCL) reported full-year 2025 adjusted EBITDA growth of 6% to $199 million, despite a challenging macro environment and missing Q4 EPS expectations. The company announced "Project Catalyst," a comprehensive plan to optimize its asset base and deliver approximately $100 million in pretax savings over the next two years, including the closure of its Fieldsboro, New Jersey site. Stepan expects EBITDA growth and positive free cash flow in 2026, with performance heavily skewed towards the second half due to improving oleochemical costs, Project Catalyst savings, and anticipated demand recovery.
Stepan (SCL) Launches Project Catalyst to Drive $100M in Cost Savings
Stepan Company (NYSE: SCL) has initiated "Project Catalyst," a restructuring and efficiency program designed to achieve approximately $100 million in pre-tax cost savings over the next two years. The plan involves consolidating production, optimizing processes, and closing facilities in New Jersey and parts of Illinois and the U.K. These efforts aim to simplify operations, reduce costs, improve shareholder returns, and position the company for more stable long-term growth.
Stepan Company Earnings Call Signals Cost-Focused Pivot
Stepan Company's Q4 earnings call revealed a cautiously optimistic outlook, with management highlighting solid full-year EBITDA growth and stronger cash generation, despite near-term profitability pressures due to cost inflation and weaker demand. The company is embarking on "Project Catalyst," an aggressive cost-savings initiative aiming for $100 million in savings over two years, with significant impact expected in 2026. This strategic reset, coupled with the ramp-up of their new Pasadena facility and targeted growth in specific markets, positions Stepan for a stronger performance by the second half of 2026.
Stepan Company (NYSE: SCL) unveils $100M Project Catalyst after 2025 results
Stepan Company reported mixed financial results for 2025, with net sales increasing by 7% to $2.33 billion but reported net income declining by 7% to $46.9 million due to higher interest expenses and a goodwill impairment. The company launched "Project Catalyst," aiming for $100 million in pre-tax savings over two years through footprint optimization, including site closures and asset decommissioning. Stepan also declared a quarterly dividend of $0.395 per share, continuing its 58-year streak of dividend increases.
Stepan Company (NYSE: SCL) unveils $100M savings plan with plant closure
Stepan Company has launched "Project Catalyst," an operational and efficiency plan designed to achieve approximately $100 million in pre-tax savings over the next two years. This initiative involves closing its Fieldsboro, New Jersey site and decommissioning assets at its Elwood, Illinois, and Stalybridge, UK facilities by mid-2026 to consolidate production and optimize its global manufacturing footprint. The company anticipates incurring $70-$80 million in restructuring charges in 2026, with a significant portion expected in the first quarter.
Stepan Co. (SCL) Reports Q4 Loss, Misses Revenue Estimates
Stepan Co. (SCL) reported a Q4 loss of $0.02 per share, missing the Zacks Consensus Estimate of $0.35, and revenues of $553.89 million, also below estimates. Despite this performance, the company's shares have added about 42% since the beginning of the year. The stock currently holds a Zacks Rank #3 (Hold), indicating it is expected to perform in line with the market.
Stepan Co. (SCL) Reports Q4 Loss, Misses Revenue Estimates
Stepan Co. (SCL) reported a Q4 loss of $0.02 per share, missing the Zacks Consensus Estimate of $0.35, and revenues of $553.89 million, also below estimates. Despite outperforming the market year-to-date with a 42% stock increase, the company holds a Zacks Rank #3 (Hold), indicating expected market-aligned performance. Investors are advised to monitor future earnings estimate revisions and industry outlook for further stock movement insights.
STEPAN ($SCL) Releases Q4 2025 Earnings
STEPAN ($SCL) announced its Q4 2025 earnings, reporting -$0.02 per share and revenues of $553,890,000, both missing analyst estimates. The stock price declined by 2.15% since market open. Hedge fund activity shows mixed sentiment, with 109 institutions adding and 122 decreasing their positions in the company.
Stepan Co.: Q4 Earnings Snapshot
Stepan Co. reported earnings of $5 million, or 22 cents per share, in its fourth quarter. Losses, after adjustments, amounted to 2 cents per share, with total revenue reaching $553.9 million. For the entire year, the company's profit was $43.9 million, or $2.05 per share, on revenue of $2.33 billion.
Stepan Co recently released a project impact forecast, estimating that the cash impact over the entire project cycle will range between $29 million and $44 million, while the non-cash impact is expected to be between $58 million and $62 million.
Stepan Co has released a project impact forecast, predicting a cash impact of $29 million to $44 million and a non-cash impact of $58 million to $62 million over the project's cycle. This forecast is based on current project progress and market conditions, with actual impacts potentially subject to adjustment. The company differentiates cash outflow from non-cash accounting treatments like asset impairment.
Stepan Company Announces $100 Million Pre-Tax Cost Out and Efficiency Plan to Support Global Operations Optimization
Stepan Company announced "Project Catalyst," a comprehensive operational and efficiency plan aimed at achieving approximately $100 million in pre-tax savings over the next two years. The plan involves optimizing its global manufacturing footprint, including the closure of its Fieldsboro, NJ site and decommissioning select assets in Illinois and the UK, to improve productivity, reduce costs, and strengthen its competitive position. The company expects to incur $70 to $80 million in restructuring charges in 2026, primarily in Q1, as it streamlines operations.
$100M cost drive: Stepan to shut NJ chemical site, cut assets in US and UK
Stepan Company announced "Project Catalyst," a plan to achieve about $100 million in pre-tax savings over two years through manufacturing consolidation, process improvements, and organizational changes. This includes closing its Fieldsboro, NJ site and decommissioning assets in Elwood, IL, and Stalybridge, UK, with actions expected to be completed by mid-2026. The company anticipates restructuring charges of $70–80 million in 2026 to implement these changes.
Stepan Declares Quarterly Dividend
Stepan Company's Board of Directors has declared a quarterly cash dividend of $0.395 per share, payable on March 13, 2026, to stockholders of record on March 2, 2026. This marks the 58th consecutive year the company has increased its cash dividend, following a $0.010 per share increase in the fourth quarter of 2025. Stepan Company is a chemical manufacturer specializing in surfactants, polyurethane polyols, and other specialty chemicals.
Stepan Co.: Q4 Earnings Snapshot
Stepan Co. (SCL) reported fourth-quarter earnings of $5 million, or 22 cents per share, with adjusted losses of 2 cents per share. The specialty chemicals company achieved revenues of $553.9 million for the quarter. For the full year, Stepan Co. reported a profit of $46.9 million, or $2.05 per share, on revenues of $2.33 billion.
Stepan Reports Fourth Quarter and Full Year 2025 Results
Stepan Company reported its fourth-quarter and full-year 2025 results, with reported net income up 49% for Q4 but down 7% for the full year. The company's adjusted EBITDA grew 6% for the full year, despite challenges like increased raw material costs and start-up expenses. Stepan also announced "Project Catalyst," a plan to optimize assets and achieve approximately $100 million in pre-tax savings over the next two years, including facility closures and asset decommissioning.
Stepan Q4 2025 earnings preview
This article provides a preview of Stepan's (NYSE: SCL) Q4 2025 earnings. It is important for investors to be aware of the company's past performance and any recent analyst revisions to properly assess its financial health.
Stepan faces earnings test as margin expansion comes into focus
Stepan Company is set to report fourth-quarter results, with analysts expecting 40 cents per share on revenue of $570.6 million. Investors will focus on margin trajectory, the ramp-up of its Pasadena alkoxylation facility, Surfactants pricing, and the recovery of its Polymers segment. The company's turnaround narrative, supported by recent divestitures and an improved balance sheet, will be tested as it aims to justify its current valuation and sustain stock momentum.
Stepan Company Is Quietly Running Your Everyday Life – But Is SCL Stock a Secret Cheat Code or a Total Snooze?
Stepan Company, a low-profile chemical giant, is an integral but unseen part of everyday products, from cleaning supplies to industrial materials. The article explores whether its stock (SCL) represents a solid, long-term investment for those seeking stability over high-flying, trendy stocks. While not a flashy consumer brand, Stepan supplies key chemical ingredients to other companies, making it a "behind-the-scenes" player that might appeal to investors focused on diversified, fundamental portfolios.
Stepan Company Is Quietly Running Your Everyday Life – But Is SCL Stock a Secret Cheat Code or a Total Snooze?
Stepan Company (SCL) is a low-profile chemical giant whose products are integral to many everyday items, from cleaning supplies to industrial materials. While not a flashy consumer brand, its stock is being examined for long-term investment due to its role as a stable, industrial supplier. The article explores whether SCL is a boring but potentially solid investment for those seeking diversified portfolios over meme-stock volatility.
